Catherine Wright, MD
Otolaryngology · Dover, DENPI 1194938142
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $453 of the $606 with a category attached, or 74.7%. It is spread thinly across 11 manufacturers, the largest accounting for just 20.9%. 2025 is the largest year on record at $290, 3.8 times the $76 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in DE, where the typical reported total is $1,648.
Across 23 payments — averaging $26.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$127
- Regeneron Healthcare Solutions, Inc.$119
- Smith+Nephew$74
- GSK$63
- Intersect ENT, Inc.$55
- Sanofi-aventis U.S. LLC$55
- plus $113 from 5 others
What the payments were for
- Food & beverage$45375%
- Education$15325%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 7 | $127 |
| Regeneron Healthcare Solutions, Inc. | 2 | $119 |
| Smith+Nephew | 2 | $74 |
| GSK | 3 | $63 |
| Intersect ENT, Inc. | 1 | $55 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Stryker | 1 | $22 |
| Acclarent, Inc | 1 | $20 |
| Olympus America Inc. | 1 | $15 |
| Covidien LP | 1 | $14 |
How this compares
$606 in reported general payments places this provider in the 25th percentile of 27 otolaryngology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $43,922 |
| Azelastine Hcl | 188 | $11,422 |
| Omeprazole | 309 | $9,621 |
| Fluticasone Propionate | 202 | $4,811 |
| Pantoprazole Sodium | 154 | $4,410 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 36 | $3,833 |
| Famotidine | 171 | $3,225 |
| Mometasone Furoate | 49 | $2,628 |
| Ipratropium Bromide | 57 | $2,206 |
| Ofloxacin | 29 | $1,177 |
| Levocetirizine Dihydrochloride | 28 | $742 |
| Esomeprazole Magnesium | 24 | $493 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $243 |
| Mupirocin | 35 | $230 |
| Montelukast Sodium | 12 | $150 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Dover
- Christopher KennelDover$2K
- David LaffertyNewark$9K
- Jagdeep HundalNewark$6K
- Paul ImberWilmington$5K
- Udayan ShahWilmington$5K
- Todd SpockNewark$4K
- Joan CokerWilmington$3K
- Michael TeixidoWilmington$3K
- Mindy RabinowitzWilmington$3K
- Robert WardlowNewark$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.